Clinical Trial

EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025

WATERTOWN, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing…

5 months ago

Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025

SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on…

5 months ago

COTA partners with LCP Health Analytics to advance the use of US RWD to support HTA decision making internationally

US + UK Data to Address Key Evidence Gaps in Access to Medicines NEW YORK, July 30, 2025 /PRNewswire/ --…

5 months ago

AI Just Got a Green Light from the White House–Here’s What That Means for Healthcare Stocks

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 29, 2025 /PRNewswire/ -- Equity Insider News…

5 months ago

Panome Bio Multi-omics Laboratory Enhances Clinical Capabilities with CLIA Certification

ST. LOUIS, July 29, 2025 /PRNewswire/ -- Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced…

5 months ago

Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics

CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave™ Ultrasound Imaging SystemThe VxWave Ultrasound Imaging System…

5 months ago

Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback

LAS VEGAS, July 29, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company…

5 months ago

Unlearn Appoints Its First Vice President of Product

Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovationSAN…

5 months ago

AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering

OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing…

5 months ago

Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the…

5 months ago